Patricia Silva, PhD

Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Patricia Silva, PhD

September 23, 2016 News by Patricia Silva, PhD

Patricia Silva, PhD

Articles by Patricia Silva, PhD

#ECTRIMS2016 – Primary Progressive MS Patients May Soon Have Ocrevus as Treatment

Protein Biomarker Identified for MS May Predict Disease Severity, Treatment Response

#ECTRIMS2016 – Novartis’s Siponimod Appears to Slow SPMS Progression in Phase 3 Study

#ECTRIMS2016 – 2 Rounds of Lemtrada Seen to Effectively Treat MS Relapses for Years

#ECTRIMS2016 – Few Serious Autoimmune Reactions to Lemtrada Treatment Seen in 3 MS Clinical Trials

#ECTRIMS2016 – MS Patients on Oral Gilenya Stick Longer with Treatment in Phase 4 Study

REAL MS Inviting Patients to Join Research Project Aiming to Promote More Personalized Care

#ECTRIMS2016 – GeNeuro Reaches Enrollment Halfway Mark in Study of GNbAC1 to Treat Multiple Sclerosis

#ECTRIMS2016 – Sanofi Releases Patients’ Views of Aubagio as Effective Treatment for Relapsing MS

#ECTRIMS2016 – Antioxidant Lipoic Acid Appears to Slow SPMS Patients’ Neurodegeneration

#ECTRIMS2016 – Data on Merck Treatment for Relapsing MS, Cladribine Tablets, Show Long-Term Benefit

#ECTRIMS2016 – Treatment of Progressive MS May Have Delayed Result

#ECTRIMS2016 – Brain MRI Scans Can Predict Which Patients Will Progress into SPMS

#ECTRIMS2016 – Biogen and AbbVie Present New Positive Data on Zinbryta to Treat Relapsing MS

#ECTRIMS2016 – Researchers Disagree on Feasibility of MS Bone Marrow Transplants

#ECTRIMS2016 – MS Patients’ Perceptions of Exercise Key to Their Participation

#ECTRIMS2016 – Inflammatory Profiles of Brain Seen to Predict MS Disability

#ECTRIMS2016 – Eye Imaging Tools May Help Predict 5- or 10-Year MS Disability

#ECTRIMS2016 – Immune Cells Linked to Autoimmunity Found in MS Patients’ Gut

#ECTRIMS2016 – Children with MS at Considerable Risk of Psychiatric Disorders

#ECTRIMS2016 – Escalation vs. Induction Treatment for Early MS Topic of Debate

#ECTRIMS2016 – Eye Imaging, Genetics Link Immune Complement Factors to MS Progression

#ECTRIMS2016 – MS Care in Latin America Suffers from Lack of Healthcare Resources

#ECTRIMS2016 – MS Care and Research Lagging in Middle East, Experts Say

#ECTRIMS2016 – Danish Children of MS Parents Perform Better Than Average in School

Gladstone Scientist Wins $5.8M NINDS Award for Work in MS and Neurological Diseases

#ECTRIMS2016 – Biogen to Unveil Study into Economic and Human Costs of MS

5 Canadians Studying for Future in Multiple Sclerosis Research Awarded Scholarships

1st Generic for Copaxone to Treat Relapsing MS Available in Central and Eastern Europe

Parents of Youngsters with MS Voice Needs and Frustrations in Study

Subscribe to our newsletter